The trajectory of the erectile dysfunction drug presents a intricate picture for shareholders. While the initial launch generated massive gains, the lapse of its intellectual property protection opened the floodgates https://bookmarklogin.com/story21795709/viagra-and-the-pharmaceutical-industry-a-risky-investment